These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 1091162

  • 1. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ.
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract] [Full Text] [Related]

  • 2. Therapy with injectable fluphenazines.
    Ayd FJ.
    Curr Psychiatr Ther; 1976 May; 16():177-89. PubMed ID: 991628
    [No Abstract] [Full Text] [Related]

  • 3. Side effects of depot fluphenazines.
    Ayd FJ.
    Adv Biochem Psychopharmacol; 1974 May; 9(0):301-9. PubMed ID: 4599435
    [No Abstract] [Full Text] [Related]

  • 4. Side effects of depot fluphenazines.
    Ayd FJ.
    Compr Psychiatry; 1974 May; 15(4):277-84. PubMed ID: 4607070
    [No Abstract] [Full Text] [Related]

  • 5. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP, Cole JO.
    Am J Psychiatry; 1973 Jan; 130(1):13-8. PubMed ID: 4566388
    [No Abstract] [Full Text] [Related]

  • 6. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
    Smulevich AB, Minsker EI, Mazaeva NA, Volkova RP, Lukanina SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(6):912-20. PubMed ID: 5050051
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Depot fluphenazine: risk/benefit ratio.
    Glazer WM.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [Abstract] [Full Text] [Related]

  • 9. [Clinical experiences with a delayed-action preparation of fluphenazine].
    Schwingenheuer J.
    Arzneimittelforschung; 1972 Nov; 22(11):1918-21. PubMed ID: 4633589
    [No Abstract] [Full Text] [Related]

  • 10. Iatrogenic morbidity in patients taking depot fluphenazine.
    Jose C, Mallya A, Mehta D, Evenson R, Holland R.
    Am J Psychiatry; 1979 Jul; 136(7):976-7. PubMed ID: 453363
    [No Abstract] [Full Text] [Related]

  • 11. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ.
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [Abstract] [Full Text] [Related]

  • 12. Extrapyramidal symptoms in the course of fluphenazine treatment.
    Bastecký J, Vinar O, Taussigová D.
    Act Nerv Super (Praha); 1972 May; 14(2):97-9. PubMed ID: 5040184
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W.
    Med Welt; 1970 Oct 10; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract] [Full Text] [Related]

  • 18. Drug-induced dystonia.
    Swett C.
    Am J Psychiatry; 1975 May 10; 132(5):532-4. PubMed ID: 1119613
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.